Insomnia is a common medical condition treated with a variety of pharmacologic (Rx or OTC) and non-pharmacologic options. Yet, little data exist on long-term efficacy and safety on these treatment options. Join host Geoff Wall as he discusses a recent meta-analysis comparing treatments for insomnia.

The GameChanger
All treatments for insomnia, including melatonergic agonists, have poor tolerability. Eszopiclone may be the best tolerated and effective “Z” medication for treatment of insomnia.

Show Segments 
00:00 - Introductions 
01:24 - Insomnia 
04:20 - Insomnia Treatment Options 
19:25 - The GameChanger 
21:36 - Connecting to Practice 
24:06 - Closing Remarks 

 Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

 References and resources:
Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.

Redeem your CPE or CME credit

• CPE (Pharmacist) 
• CME (Physician) 

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) 

• Pharmacists: Get a Membership 
• Prescribers: Get a Membership  

 
Continuing Education Information:
Learning Objectives:
1. Discuss the results of a recent network meta-analysis on treatments of insomnia
2. Compare different pharmacotherapy options for the treatment of insomnia based on a recent meta-analysis


0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-304-H01-P
Initial release date: 08/22/22
Expiration date: 08/22/2023
Additional CPE & CME details can be found here 

Follow CEimpact on Social Media:
LinkedIn
Instagram